New anti-cancer therapy: Converting glioma cells into neurons
(Guangdong-Hongkong-Macau Institute of CNS Regeneration,Jinan University) Glioma is a fatal neurological disorder that has limited interventional treatment, despite extensive research over the past several decades. A research team led by Dr. Gong Chen,has developed a novel gene therapy to reprogram glioma cells into functional neurons, shedding new light on glioma treatment. The work has been published in Cancer Biology& Medicine on March 22, 2021 (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 23, 2021 Category: Cancer & Oncology Source Type: news
Combination treatment for common glioma type shows promise in mice
NIH-funded preclinical study suggests new approach to treat a type of brain tumor (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - February 16, 2021 Category: American Health Source Type: news
Combination treatment for common glioma type shows promise in mice
(NIH/National Institute of Neurological Disorders and Stroke) Gliomas are common brain tumors that comprise about one third of all cancers of the nervous system. In a study funded by the National Institutes of Health (NIH), researchers tested a novel combination treatment approach on mice with tumors with characteristics similar to human astrocytomas and found tumor regression in 60 percent of the mice treated. These encouraging results could be the first step toward developing a treatment for this type of brain cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 16, 2021 Category: Cancer & Oncology Source Type: news
Can Brain Stem Glioma Be Cured
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - January 20, 2021 Category: General Medicine Source Type: news
Toxoplasma Gondii Infection May Be Tied to Higher Risk of Brain Cancer Toxoplasma Gondii Infection May Be Tied to Higher Risk of Brain Cancer
Data from two prospective studies point to an association between Toxoplasma gondii infection and the risk of glioma in adults, suggesting that reducing exposure could provide an avenue to modify glioma risk, the researchers say.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - January 14, 2021 Category: Infectious Diseases Tags: Hematology-Oncology News Source Type: news
Link Between T. gondii Infection, Glioma Risk Examined
Significant increase in glioma risk seen for those with higher antibody titers to the sag - 1 antigen (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 12, 2021 Category: Cancer & Oncology Tags: Infections, Neurology, Oncology, Pathology, Journal, Source Type: news
Toxin in Undercooked Meat Shows Links to Rare Brain Tumors
TUESDAY, Jan. 12, 2021 -- A foodborne pathogen may be linked to a type of rare brain cancer in adults, a new study suggests.
Researchers found that people who have glioma are more likely to have antibodies to toxoplasma gondii than a similar group... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 12, 2021 Category: General Medicine Source Type: news
Link Between T. gondii Infection, Glioma Risk Examined
TUESDAY, Jan. 12, 2021 -- Some evidence suggests that there is an increased risk for glioma among individuals who have had Toxoplasma gondii infection, according to a study published online Jan. 11 in the International Journal of Cancer.
James M.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 12, 2021 Category: Pharmaceuticals Source Type: news
Study identifies exposure to common food-borne pathogen linked to rare brain cancer
(American Cancer Society) A new study suggests a link between toxoplasma gondii (T. gondii) infection and the risk of glioma, a type of brain cancer, in adults. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 11, 2021 Category: Cancer & Oncology Source Type: news
Philadelphia biotech firm acquired for $78M by North Carolina company with eye on cancer treatment
The North Carolina biopharmaceutical firm is aiming to boost its pipeline of drugs designed to combat recurrent glioma – a form of brain cancer. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - January 8, 2021 Category: Health Management Authors: Cameron Snipes Source Type: news
Durham biotech makes $78M deal for Philly firm to boost platform for cancer treatment
The Durham-based biopharmaceutical firm is aiming to boost its pipeline of drugs designed to combat recurrent glioma – a form of brain cancer. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 8, 2021 Category: Pharmaceuticals Authors: Cameron Snipes Source Type: news
Durham biotech makes $78M deal for Philly firm to boost platform for cancer treatment
The Durham-based biopharmaceutical firm is aiming to boost its pipeline of drugs designed to combat recurrent glioma – a form of brain cancer. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - January 8, 2021 Category: American Health Authors: Cameron Snipes Source Type: news
Combination Treatment Fails to Improve Survival in Recurrent Glioma Combination Treatment Fails to Improve Survival in Recurrent Glioma
Following tumor resection in patients with recurrent glioblastoma and anaplastic astrocytoma, treatment with vocimagene amiretrorepvec and with flucytosine provides no improvement in overall survival, according to an open-label phase 2/3 trial.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 5, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Tumor DNA in spinal fluid could help doctors better monitor childhood brain cancer
(Michigan Medicine - University of Michigan) Researchers have demonstrated that a new liquid biopsy approach overcomes traditional barriers to quickly and efficiently diagnose and monitor high-grade pediatric gliomas. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 21, 2020 Category: Cancer & Oncology Source Type: news
